ClinVar Miner

Submissions for variant NM_153676.4(USH1C):c.1823C>G (p.Pro608Arg)

dbSNP: rs41282932
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000041259 SCV000064950 likely benign not specified 2015-02-06 criteria provided, single submitter clinical testing p.Pro608Arg in exon 18 of USH1C: This variant has been previously reported in 3 individuals with Usher syndrome or hearing loss and 2 individuals by our laborat ory; 3 of whom have another genetic etiology to explain their hearing loss (Crem ers 2007, Vera 2014, LMM unpublished data). This variant has also been identifie d in 0.1% (51/60306) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs41282932). In summary, the prese nce of this variant in 3 individuals with another etiology for hearing loss and its frequency in the general population suggest that it is likely benign.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000755427 SCV000605534 uncertain significance not provided 2018-05-25 criteria provided, single submitter clinical testing The p.Pro608Arg variant (rs41282932) has been identified in a homozygous state in a single induvial with non-syndromic hearing loss (Ouyang 2002). However it has been identified in several other cases with an alternate molecular basis for hearing loss, suggesting that it is not a causative variant (Cremers 2007, and Vona 2014). The p.Pro608Arg variant has also been reported to ClinVar (Variation ID: 5148). This variant is listed in the NHLBI GO Exome Sequencing Project with an overall population frequency of 0.06 percent (identified on 8 out of 12,984 chromosomes) and is listed in the Genome Aggregation Database (gnomAD) with an overall population frequency of 0.05 percent (identified on 124 out of 267,276 chromosomes). The proline at position 608 is weakly conserved (considering 12 species) (Alamut v.2.8.1) and computational analyses of the effects of the p.Pro608Arg variant on protein structure and function provide conflicting results (SIFT: tolerated, MutationTaster: disease causing, PolyPhen-2: possibly damaging). Altogether, there is not enough evidence to classify the p.Pro608Arg variant with certainty.
Otology & Neurotology- Genomics of vestibular disorders (CTS-495), Jose Antonio López Escámez, Centro Pfizer - Universidad de Granada - Junta de Andalucía de Genómica e Investigación Oncológica (GENYO) RCV001797045 SCV001738474 uncertain significance Meniere disease 2021-06-21 criteria provided, single submitter case-control Digenic inheritance along with NM_000260.4:c.6247G>A(MYO7A)
GeneDx RCV000755427 SCV001873907 uncertain significance not provided 2024-10-31 criteria provided, single submitter clinical testing Observed as a heterozygous variant in patients with hearing loss who harbored variants in other hearing loss-related genes (PMID: 16963483, 24875298, 29739340, 34391192); In silico analysis indicates that this missense variant does not alter protein structure/function; Reported using an alternate transcript of the gene; This variant is associated with the following publications: (PMID: 34391192, 24875298, 29739340, 30245029, 34426522, 12136232, 16963483)
Myriad Genetics, Inc. RCV001276292 SCV002060018 uncertain significance Usher syndrome type 1C 2021-10-08 criteria provided, single submitter clinical testing NM_005709.3(USH1C):c.1285-7566C>G is an intronic variant classified as a variant of uncertain significance in the context of USH1C-related disorders. c.1285-7566C>G has been observed in cases with relevant disease (PMID: 12136232, 29739340, 16963483, 24875298). Functional assessments of this variant are not available in the literature. c.1285-7566C>G has been observed in population frequency databases (gnomAD: NFE 0.08%). In summary, there is insufficient evidence to classify NM_005709.3(USH1C):c.1285-7566C>G as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening.
Labcorp Genetics (formerly Invitae), Labcorp RCV000755427 SCV003255845 likely benign not provided 2023-10-11 criteria provided, single submitter clinical testing
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg RCV004814838 SCV005070778 uncertain significance Optic atrophy 2022-01-01 criteria provided, single submitter clinical testing
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg RCV004814837 SCV005073502 uncertain significance Retinal dystrophy 2022-01-01 criteria provided, single submitter clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV005394121 SCV006059165 uncertain significance Usher syndrome type 1C; Autosomal recessive nonsyndromic hearing loss 18A; Usher syndrome type 1 2022-02-15 criteria provided, single submitter research
OMIM RCV000005455 SCV000025637 pathogenic Autosomal recessive nonsyndromic hearing loss 18A 2002-07-01 no assertion criteria provided literature only
Natera, Inc. RCV001276292 SCV001462402 uncertain significance Usher syndrome type 1C 2020-04-11 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.